Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 476

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 4
Chunk 476
---
 based solely on the Schedule 13G filed by Indemnity National Insurance Company on November 7, 2023. Indemnity National
    Insurance Company’s address is 238 Bedford Way, Franklin, Tennessee 37064. 

Item
13. Certain Relationships and Related Transactions, and Director Independence

Transactions
with Related Persons

During
the year ended December 31, 2024, the Company sold all of its common stock of Graphium Biosciences to a newly-formed entity, Placer Biosciences,
Inc. (“Placer”), owned by two former officers of the Company, in exchange for a warrant to purchase 1,000 shares of Placer’s
common stock (then representing 25% of the outstanding shares of Placer) at $0.01 per share and cash proceeds of $100. The warrant to purchase Placer’s shares expires September 30, 2034.

On January 21, 2025, the Company
entered into a securities purchase agreement with Tower IV, LLC, an Ohio limited liability company (“Tower IV”), providing
for the issuance and sale by the Company to Tower IV of an aggregate of 3,333,333 shares of the Company’s common stock (the “Shares”)
at a price of $0.15 per share. The aggregate gross proceeds from the sale of the Shares are approximately $500,000. Mr. Joseph E. LoConti
is the beneficial owner of Tower IV.

During
the year ended December 31, 2023, and through the filing of this Annual Report, except for the Graphium sale and investment by Tower
IV, LLC listed above, there have been no transactions, and there are no currently proposed transactions, in which we were or are to
be a participant and the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at
year-end for the last two completed fiscal years and in which any related person had or will have a direct or indirect material
interest.

Director
Independence

Our
Board of Directors has determined that Messrs. Feighan and Celeste would qualify as “independent” as that term is defined
by Nasdaq Listing Rule 5605(a)(2). Mr. Cavanaugh would not qualify as “independent” because he currently serves as our Chief
Executive Officer.

Item
14. Principal Accounting Fees and Services

Independent
Registered Public Accounting Firm’s Fee Summary

The
following table